Dohmen

Recent executive movements at Eversana

Tim Guttman, Chief Financial Officer, has left the company  (news posted on May 4 2020).
Kelly Baker has joined the company as Chief Financial Officer  (news posted on May 4 2020).

Create an alert
to follow the executive moves at Dohmen.

Most searched biographies at Dohmen

• Cynthia LaConte, Chief Executive Officer and President
• Dale Mittelstaedt, President, Chief Innovation Officer and Preside...
• Michael Italiano, Chief Financial Officer

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about Dohmen

Dohmen on Wikipedia, Google News & Yahoo Finance

Dohmen on LinkedIn, Twitter & YouTube

Dohmen has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland). Dohmen is owned by Eversana.

Contact by email its executives including Cynthia LaConte

Call Dohmen at +1 414....

View the org chart

Register to receive your alert

Report an error